Search Results
11 protocol(s) meet the specified criteria
102833Open  
Randomized Phase III Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) Compared with CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis

103123Open  
Multicenter, Phase I, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy, and Pharmacokinetics in Patients with Advanced Malignancies

103695Open  
Pilot Trial Evaluating the Combination of Reolysin and Carfilzomib in Multiple Myeloma

106209Open  
Expanded Access Program for Ivosidenib (AG-120) Monotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation

79885Open  
Open-Label, Dose-Escalation and Multicenter Study to Evaluate the Safety and Pharmacokinetics of SAR650984 in Patients with Relapsed/Refractory Multiple Myeloma

87890Open  
Phase I Study of BLU-285 in Patients with Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies

94455Open  
Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment with Adjuvant Systemic Treatment and Zoledronic Acid versus Zoledronic Acid after Definite Radiation Therapy

95978Open  
Phase IB Study of the Safety and Pharmacokinetics of Atezolizumab (Anti Pd L1 Antibody) Alone or in Combination with an Immumomodulatory Drug and/or Daratumumab in Patients with Multiple Myeloma (Relapsed/Refractory and Post Autologous Stem Cell Transplantation)

96767Open  
Phase II, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

98381Open  
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

99122Open  
Phase II, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement